On April 27, 2019, the launching ceremony of the Sichuan Biotherapy Clinical Medical Research Center was held, together with the inaugural meeting of the SCIMEA Biological Immunotherapy Professional Committee and the first West China Biological Immunotherapy Forum. The event was attended by Tian Yunhui, member of the Party Leadership Group and Deputy Director General of the Science & Technology Department of Sichuan Province, Wei Yuquan, Academician of the Chinese Academy of Sciences, Director of the Sichuan Biotherapy Clinical Medical Research Center, and President of the Sichuan International Medical Exchange & Promotion Association (SCIMEA), and Zhang Mengfan, Secretary General of the SCIMEA. 

        Deputy Director General Tian extended his congratulations on the launch of the Biomedical Clinical Medical Research Center and the establishment of the SCIMEA Biological Immunotherapy Professional Committee. He indicated that, the province has always attached great importance to the development of biological immunotherapy, and treated it as one of the major tasks in the domain of clinical transformation and medical advancement; as tumor diseases have gradually become the focus of national clinical medical research, our province is also offering strong support through subsidies for the related platforms constructed, approval of related research projects, international science and technology exchanges and cooperation, and talent programs; in 2017, the province initiated the construction of provincial clinical medical research centers, Sichuan Science & Technology Department, the provincial Health and Family Planning Commission, and the provincial Food and Drug Administration, and the provincial Traditional Chinese Medicine Bureau jointly issued the Administrative Measures for Clinical Medical Research Centers in Sichuan (Trial), established the first batch of 12 clinical medical research centers, and support them in the form of post-construction subsidies; in the next step, the province will strive to apply for the fourth batch of national clinical medical research centers, and select and construct more provincial-level clinical medical research centers. He hopes that all experts will take advantages of their leading positions in respective disciplines, play well their guiding roles, build a public service platform for clinical research, focus on the major needs and critical common problems in the field of cancer prevention and treatment; take the lead in organizing and coordinating the construction of innovative network, tackle technical thorny issues, cultivate leading talents, transform and popularize research results, improve the capability of grassroots medical services, and make significant contributions to boosting the level of disease prevention and control, and promoting the transformation of medical science and technology achievements in our province.

Academician Wei said, in January this year, the "Sichuan Biotherapy Clinical Medical Research Center", the establishment of which was jointly applied for by the West China Hospital of Sichuan University and other 17 units, was approved by the Province's Science & Technology Department, Health and Family Planning Commission, Food and Drug Administration, and Traditional Chinese Medicine Bureau. He expressed sincere gratitude toward the Science & Technology Department and other competent authorities for their great support and thoughtful guidance. Academician Wei claimed that, the Center is a provincial level technology innovation & achievement transformation-oriented research base, which is established to suit the province's disease prevention and treatment needs, guided by clinical application, based on hospitals and supported by collaborative networks, and gets involved in joint research, academic exchanges, talent training, as well as achievements transformation, promotion and application; the member units of the Center will share advantages and resources, conduct multi-center clinical research, gear up clinical results transformation and personnel training, and facilitate the enhancement of biological immunotherapy capabilities of medical institutions at various levels in Sichuan.

         Deputy Director General Tian Yunhui awarded the plate to Sichuan Biotherapy Clinical Medical Research Center.

Deputy Director General Tian and Academician Wei awarded plates to member units of the Sichuan Biotherapy Clinical Medical Research Center.

Group Shot

Attachment: List of the Member Units of the "Sichuan Biotherapy Clinical Medical Research Center"